FDA Approves Higher-Dose Version of Aflibercept
The FDA approved a higher dosage of aflibercept (Eylea) for the treatment of age-related macular degeneration, macular edema, and diabetic retinopathy.
Source: ajmc.com
With Eylea News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from With Eylea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In With Eylea Today - Breaking & Trending Today